Robert E. Sulentic - 05 Mar 2025 Form 4 Insider Report for CBRE GROUP, INC. (CBRE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Mar 2025, 16:58:53 UTC
Prior SEC filing
05 Mar 2025
Next SEC filing
12 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cindy Kee, Attorney-in-Fact for Robert E. Sulentic

Key filing fact

Robert E. Sulentic filed Form 4 for CBRE GROUP, INC. (CBRE) on 07 Mar 2025.

Key facts

  • This page summarizes Robert E. Sulentic's Form 4 filing for CBRE GROUP, INC. (CBRE).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Mar 2025, 16:58.

Change

  • Previous filing in this sequence was filed on 05 Mar 2025.
  • Current net transaction value: -$710,219.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CBRE transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+42,047
Change %
+3.4%
Price
$0.000000
Shares after
1,297,094
Date
05 Mar 2025
Ownership
Direct
Footnotes
F1
CBRE transaction

Class A Common Stock

Tax liability

Transaction value
$710,219
Shares
-4,991
Change %
-0.38%
Price
$142.30
Shares after
1,292,103
Date
05 Mar 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Issuer granted these securities to the Reporting Person on March 5, 2025 as part of the Reporting Person's 2025 annual equity award. These securities will vest at a rate of 25% per year on each of March 5, 2026, 2027, 2028 and 2029, subject to forfeiture or acceleration in certain circumstances as set forth in the award agreement for these securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .